Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Immunocytokines Market Portraiture
2.2. Global Immunocytokines Market, By Disease Indication, 2018 (US$ Mn)
2.3. Global Immunocytokines Market, By Target Site, 2018 (US$ Mn)
2.4. Global Immunocytokines Market, by Geography, 2018 vs. 2026 (Value %)
Chapter 3. Global Immunocytokines Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Immunocytokines: Future Trends
3.3. Current Scenario: Prevalence for Cancer
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2018
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2018
Chapter 4. Global Immunocytokines Market, By Disease Indication, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Tumors and Cancer
4.3. Rheumatoid Arthritis
Chapter 5. Global Immunocytokines Market, By Target Site, 2017 (US$ Mn)
5.1. Overview
5.2. Liver
5.3. Hypothalamus
5.4. Fat muscle
5.5. B and T lymphocytes
5.6. Bone Marrow Endothelium
Chapter 6. Global Immunocytokines Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Immunocytokines Market Analysis, 2016 – 2026
6.2.1. North America Immunocytokines Market, By Disease Indication, 2016 – 2026 (US$ Mn)
6.2.2. North America Immunocytokines Market, By Target Site, 2016 – 2026 (US$ Mn)
6.2.3. North America Immunocytokines Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Immunocytokines Market Analysis, 2016 – 2026
6.3.1. Europe Immunocytokines Market, By Disease Indication, 2016 – 2026 (US$ Mn)
6.3.2. Europe Immunocytokines Market, By Target Site, 2016 – 2026 (US$ Mn)
6.3.3. Europe Immunocytokines Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Immunocytokines Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Immunocytokines Market, By Disease Indication, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Immunocytokines Market, By Target Site, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Immunocytokines Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Immunocytokines Market Analysis, 2016 – 2026
6.5.1. Latin America Immunocytokines Market, By Disease Indication, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Immunocytokines Market, By Target Site, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Immunocytokines Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Immunocytokines Market Analysis, 2016 – 2026
6.6.1. MEA Immunocytokines Market, By Disease Indication, 2016 – 2026 (US$ Mn)
6.6.2. MEA Immunocytokines Market, By Target Site, 2016 – 2026 (US$ Mn)
6.6.3. MEA Immunocytokines Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. AstraZeneca Plc
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Alkermes Plc
7.3. CytImmune
7.4. Cytune Pharma
7.5. Altor Biosciences Corporation
7.6. Apeiron Biologics AG
7.7. Paladin Labs
7.8. Teva Pharmaceutical Industries Ltd.
7.9. Valor Biotherapeutics
7.10. Targa Therapeutics Corporation
7.11. Immunomedics, Inc.
7.12. ImmunGene, Inc.
7.13. MolMed S.p.A.
7.14. Merck KGaA
7.15. Nektar Therapeutics
7.16. Pfizer, Inc.
7.17. F. Hoffmann-La Roche, Ltd.
List of Figures
FIG. 1 Global Immunocytokines Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Immunocytokines Market Segmentation
FIG. 4 Global Immunocytokines Market, By Disease Indication, 2017 (US$ Mn)
FIG. 5 Global Immunocytokines Market, By Target Site, 2017 (US$ Mn)
FIG. 6 Global Immunocytokines Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key Immunocytokines Manufacturers, 2017
FIG. 9 Global Immunocytokines Market for Tumors and Cancer, 2016–2026 (US$ Mn)
FIG. 10 Globla Immunocytoines Market for Rheumatoid Arthritis, 2016–2026 (US$ Mn)
FIG. 11 Global Immunocytokines Market for Liver, 2016–2026 (US$ Mn)
FIG. 12 Global Immunocytokines Market for Hypothalamus, 2016–2026 (US$ Mn)
FIG. 13 Global Immunocytokines Market for Fat muscle, 2016–2026 (US$ Mn)
FIG. 14 Global Immunocytokines Market for B and T lymphocytes, 2016–2026 (US$ Mn)
FIG. 15 Global Immunocytokines Market for Bone Marrow Endothelium, 2016–2026 (US$ Mn)
FIG. 16 U.S. Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 17 Canada Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 18 U.K. Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 19 Germany Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 20 Rest of Europe Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 21 Japan Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 22 China Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 23 Rest of Asia Pacific Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 24 Brazil Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 25 Mexico Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 26 Rest of Latin America Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 27 GCC Immunocytokines Market, 2016–2026 (US$ Mn)
FIG. 28 Rest of Middle East & Africa Immunocytokines Market, 2016–2026 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Immunocytokines Market
TABLE 2 Global Immunocytokines Market, By Disease Indication, 2016–2026 (US$ Mn)
TABLE 3 Global Immunocytokines Market, by Geography, 2016–2026 (US$ Mn)
TABLE 4 North America Immunocytokines Market, By Disease Indication, 2016–2026 (US$ Mn)
TABLE 5 North America Immunocytokines Market, By Target Site, 2016–2026 (US$ Mn)
TABLE 6 North America Immunocytokines Market, by Country, 2016–2026 (US$ Mn)
TABLE 7 Europe Immunocytokines Market, By Disease Indication, 2016–2026 (US$ Mn)
TABLE 8 Europe Immunocytokines Market, By Target Site, 2016–2026 (US$ Mn)
TABLE 9 Europe Immunocytokines Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 10 Latin America Immunocytokines Market, By Disease Indication, 2016–2026 (US$ Mn)
TABLE 11 Latin America Immunocytokines Market, By Target Site, 2016–2026 (US$ Mn)
TABLE 12 Latin America Immunocytokines Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 13 Asia Pacific Immunocytokines Market, By Disease Indication, 2016–2026 (US$ Mn)
TABLE 14 Asia Pacific Immunocytokines Market, By Target Site, 2016–2026 (US$ Mn)
TABLE 15 Asia Pacific Immunocytokines Market, By Disease Indication, 2016–2026 (US$ Mn)
TABLE 16 Asia Pacific Immunocytokines Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 17 Middle East & Africa Immunocytokines Market, By Disease Indication, 2016–2026 (US$ Mn)
TABLE 18 Middle East & Africa Immunocytokines Market, By Target Site, 2016–2026 (US$ Mn)
TABLE 19 Middle East & Africa Immunocytokines Market, by Region, 2016–2026 (US$ Mn)
TABLE 20 Alkermes Plc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 AstraZeneca Plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Cytune Pharma: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 CytImmune: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Altor Biosciences Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Apeiron Biologics AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Paladin Labs.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Valor Biotherapeutics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Targa Therapeutics Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Immunomedics, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 ImmunGene, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 MolMed S.p.A.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Merck KGaA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Nektar Therapeutics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Pfizer, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 36 F. Hoffmann-La Roche, Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)